JP Morgan Chase’s Insmed INSM Stock Holding History

JP Morgan Chase’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-262,500	Closed	-$45.7M	–	7710
2025 Q4	$45.7M	Buy	262,500 +260,400	+12,400%	+$47.5M	﹤0.01%	1426
2025 Q3	$302K	Sell	2,100 -39,200	-95%	-$4.8M	﹤0.01%	5297
2025 Q2	$4.16M	Buy	+41,300	New	+$3.16M	﹤0.01%	3317
2024 Q4	–	Sell	-28,400	Closed	-$2.07M	–	7555
2024 Q3	$2.07M	Sell	28,400 -42,400	-60%	-$3.13M	﹤0.01%	3979
2024 Q2	$4.74M	Buy	70,800 +44,100	+165%	+$1.71M	﹤0.01%	3075
2024 Q1	$724K	Buy	+26,700	New	+$747K	﹤0.01%	4557
2023 Q4	–	Sell	-14,000	Closed	-$354K	–	7686
2023 Q3	$354K	Sell	14,000 -100,000	-88%	-$2.29M	﹤0.01%	4695
2023 Q2	$2.41M	Buy	+114,000	New	+$2.16M	﹤0.01%	3404
2022 Q1	–	Sell	-29,800	Closed	-$812K	–	6797
2021 Q4	$812K	Buy	+29,800	New	+$852K	﹤0.01%	4533
2019 Q3	–	Sell	-30,000	Closed	-$759K	–	5841
2019 Q2	$759K	Buy	+30,000	New	+$836K	﹤0.01%	4013
2019 Q1	–	Sell	-27,000	Closed	-$354K	–	5905
2018 Q4	$354K	Buy	+27,000	New	+$431K	﹤0.01%	4314
2018 Q2	–	Sell	-40,000	Closed	-$901K	–	5606
2018 Q1	$901K	Buy	+40,000	New	+$1.05M	﹤0.01%	3729

Other funds holding INSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase's INSM Position: Q1 2026 in Review

JP Morgan Chase increased its Insmed (INSM) stake by 4.1% in Q1 2026, buying an estimated $146M and bringing the position to 24,150,499 shares worth $3.7B. The position accounts for 0.24% of the portfolio, ranked #91.

JP Morgan Chase first reported a position in INSM in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.04B in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

JP Morgan Chase held 24,150,499 shares of Insmed worth $3.7B as of Q1 2026.
JP Morgan Chase bought 950,987 Insmed shares in Q1 2026, an estimated $146M.
Insmed made up 0.24% of JP Morgan Chase's portfolio in Q1 2026, its #91 holding.
JP Morgan Chase first reported a position in Insmed in Q2 2013 and has held it in 52 quarters since.
JP Morgan Chase's Insmed position peaked at $4.04B in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.